Global Chlamydia Diagnosis and Treatment Market Research and Forecast 2018-2023
Chlamydia trachomatis is a type of sexually transmitted disease that is prevalent in population of all age group, but women are much more vulnerable to it. The Chlamydia diagnosis involves a series of test such as urine culture, Nucleic acid amplification tests, Enzyme immunoassays and so on. The change in lifestyle especially related to sex preferences is the major factor driving the growth of this market, moreover, the increase in use of rapid point of care diagnosis kits also propel the market. The treatment of this disease is prolonged and usually achieved by administration of oral antibiotics to the patients. The lack of skilled practitioners for performing diagnostic test and the high cost of the tests such as Nucleic acid amplification test is the major factor for growth hindrance of market. The awareness, supportive government regulations and increased funding on development of novel diagnostic method will drive the growth of market in the forecasted period.
The market is divided into North America, Europe, Asia Pacific and Rest of the World geographically. North America region captures the major market share of Chlamydia diagnosis and treatment market due to high prevalence of disease in the region. The region also has leading diagnostic companies making it the most revenue generating region. The APAC region will grow significantly in the projected period due to rapid development in the economies and large investment in healthcare sector. The European region also holds the substantial share of the Chlamydia Diagnosis market.
The competition in Chlamydia Diagnosis market is moderate as relatively low number of companies are present in the segment, the market players are engaged in providing diagnostic tests such as Nucleic acid amplification test, Enzyme immunoassays test and rapid diagnostic test kits. The Key Players in the Chlamydia Diagnosis market are Abbott Laboratories, Hologic Inc, Laboratory Corporation of America, Novartis Diagnostics, Qiagen, Quidel Corporation, Roche Molecular Systems Inc., Siemens AG, Synapse Diagnostics, Sysmex corporation, Thermo Fisher Scientific, Tosoh Corporation and so on. The companies are also engaged in rapid research and development for the development of rapid diagnostic test kits for effective diagnosis of the disease.
RESEARCH METHODOLOGY
The market study of Global Chlamydia Diagnosis market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
Secondary sources include:
Financial reports of companies involved in the market
Authentic Public Databases (org, gov and other such websites)
Whitepapers such, research-papers and news blogs
Company websites and their product catalogue.
The Report is intended for Emerging companies and researchers in the market, Investing companies, Government Organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, growth opportunity in market, product types. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.
MARKET SEGMENTATION:
Global Chlamydia Disease Market is segmented on the basis of various regions and below mentioned segments:
Global Chlamydia Diagnosis Market Research and Analysis, By Diagnosis method
Global Chlamydia Diagnosis Market Research and Analysis, By Treatment approach
Global Chlamydia Diagnosis Market Research and Analysis, By End user
THE REPORT COVERS:
Comprehensive research methodology of Global Chlamydia Diagnosis market
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Chlamydia Diagnosis
Insights about market determinants which are stimulating the Global Chlamydia Diagnosis
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.
The market is divided into North America, Europe, Asia Pacific and Rest of the World geographically. North America region captures the major market share of Chlamydia diagnosis and treatment market due to high prevalence of disease in the region. The region also has leading diagnostic companies making it the most revenue generating region. The APAC region will grow significantly in the projected period due to rapid development in the economies and large investment in healthcare sector. The European region also holds the substantial share of the Chlamydia Diagnosis market.
The competition in Chlamydia Diagnosis market is moderate as relatively low number of companies are present in the segment, the market players are engaged in providing diagnostic tests such as Nucleic acid amplification test, Enzyme immunoassays test and rapid diagnostic test kits. The Key Players in the Chlamydia Diagnosis market are Abbott Laboratories, Hologic Inc, Laboratory Corporation of America, Novartis Diagnostics, Qiagen, Quidel Corporation, Roche Molecular Systems Inc., Siemens AG, Synapse Diagnostics, Sysmex corporation, Thermo Fisher Scientific, Tosoh Corporation and so on. The companies are also engaged in rapid research and development for the development of rapid diagnostic test kits for effective diagnosis of the disease.
RESEARCH METHODOLOGY
The market study of Global Chlamydia Diagnosis market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
Secondary sources include:
Financial reports of companies involved in the market
Authentic Public Databases (org, gov and other such websites)
Whitepapers such, research-papers and news blogs
Company websites and their product catalogue.
The Report is intended for Emerging companies and researchers in the market, Investing companies, Government Organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, growth opportunity in market, product types. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.
MARKET SEGMENTATION:
Global Chlamydia Disease Market is segmented on the basis of various regions and below mentioned segments:
Global Chlamydia Diagnosis Market Research and Analysis, By Diagnosis method
Global Chlamydia Diagnosis Market Research and Analysis, By Treatment approach
Global Chlamydia Diagnosis Market Research and Analysis, By End user
THE REPORT COVERS:
Comprehensive research methodology of Global Chlamydia Diagnosis market
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Chlamydia Diagnosis
Insights about market determinants which are stimulating the Global Chlamydia Diagnosis
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.
1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATION
2.3.1.1. UNITED STATES
2.3.1.2. EUROPEAN UNION
2.3.1.3. CHINA
2.3.1.4. INDIA
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. INCREASING PREVALENCE OF THE CHLAMYDIA TRACHOMATIS DISEASE
3.1.2. CHANGE IN LIFE STYLE
3.1.3. INCREASED ADOPTION OF POINT OF CARE DIAGNOSTIC TESTS
3.1.4. INCREASED GOVERNMENT FUNDING AND AWARENESS REGARDING DIAGNOSIS AND TREATMENT
3.2. RESTRAINT
3.2.1. LOW AWARENESS IN DEVELOPING COUNTRIES
3.2.2. PREVENTIVE MEASURES FOR STDS
3.3. OPPORTUNITY
3.3.1. RAPID DEVELOPMENT AND ADOPTION OF NON-INVASIVE, CHEAP AND RELIABLE DIAGNOSIS TECHNOLOGIES.
3.3.2. MICROFLUID DIAGNOSTIC TECHNOLOGIES ARE ENTERING THE MARKET
4. MARKET SEGMENTATION
4.1. GLOBAL CHLAMYDIA MARKET, BY DIAGNOSIS METHODS
4.1.1. CHLAMYDIA CULTURE
4.1.2. URINE CULTURE
4.1.3. ENZYME IMMUNOASSAYS
4.1.4. NUCLEIC ACID AMPLIFICATION TEST
4.2. GLOBAL CHLAMYDIA MARKET, BY TREATMENT APPROACH
4.2.1. ORAL ANTIBIOTICS
4.2.1.1. AZITHROMYCIN
4.2.1.2. DOXYCYCLINE
4.2.1.3. OTHER
4.3. GLOBAL CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET, BY END-USER
4.3.1. HOSPITALS
4.3.2. DIAGNOSTIC CENTRES
4.3.3. RESEARCH INSTITUTIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
6.2. EUROPE
6.2.1. UK
6.2.2. GERMANY
6.2.3. SPAIN
6.2.4. FRANCE
6.2.5. ITALY
6.2.6. REST OF EUROPE
6.3. APAC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. REST OF APAC
6.4. REST OF THE WORLD
7. COMPANY PROFILES
7.1. ABBOTT LABORATORIES
7.2. AETNA INC
7.3. AGILENT TECHNOLOGIES
7.4. AKERS BIOSCIENCES, INC.
7.5. BIO-RAD LABORATORIES, INC
7.6. CIGNA
7.7. CLINICAL LAB PRODUCT
7.8. DIADEXUS
7.9. ERBA DIAGNOSTICS
7.10. HOLOGIC INC
7.11. LABORATORY CORPORATION OF AMERICA
7.12. NOVARTIS DIAGNOSTICS
7.13. QIAGEN
7.14. QUIDEL CORPORATION
7.15. ROCHE MOLECULAR SYSTEMS INC.
7.16. SIEMENS AG,
7.17. SYNAPSE DIAGNOSTICS
7.18. SYSMEX CORPORATION
7.19. THERMO FISHER SCIENTIFIC
7.20. TOSOH CORPORATION
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATION
2.3.1.1. UNITED STATES
2.3.1.2. EUROPEAN UNION
2.3.1.3. CHINA
2.3.1.4. INDIA
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. INCREASING PREVALENCE OF THE CHLAMYDIA TRACHOMATIS DISEASE
3.1.2. CHANGE IN LIFE STYLE
3.1.3. INCREASED ADOPTION OF POINT OF CARE DIAGNOSTIC TESTS
3.1.4. INCREASED GOVERNMENT FUNDING AND AWARENESS REGARDING DIAGNOSIS AND TREATMENT
3.2. RESTRAINT
3.2.1. LOW AWARENESS IN DEVELOPING COUNTRIES
3.2.2. PREVENTIVE MEASURES FOR STDS
3.3. OPPORTUNITY
3.3.1. RAPID DEVELOPMENT AND ADOPTION OF NON-INVASIVE, CHEAP AND RELIABLE DIAGNOSIS TECHNOLOGIES.
3.3.2. MICROFLUID DIAGNOSTIC TECHNOLOGIES ARE ENTERING THE MARKET
4. MARKET SEGMENTATION
4.1. GLOBAL CHLAMYDIA MARKET, BY DIAGNOSIS METHODS
4.1.1. CHLAMYDIA CULTURE
4.1.2. URINE CULTURE
4.1.3. ENZYME IMMUNOASSAYS
4.1.4. NUCLEIC ACID AMPLIFICATION TEST
4.2. GLOBAL CHLAMYDIA MARKET, BY TREATMENT APPROACH
4.2.1. ORAL ANTIBIOTICS
4.2.1.1. AZITHROMYCIN
4.2.1.2. DOXYCYCLINE
4.2.1.3. OTHER
4.3. GLOBAL CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET, BY END-USER
4.3.1. HOSPITALS
4.3.2. DIAGNOSTIC CENTRES
4.3.3. RESEARCH INSTITUTIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
6.2. EUROPE
6.2.1. UK
6.2.2. GERMANY
6.2.3. SPAIN
6.2.4. FRANCE
6.2.5. ITALY
6.2.6. REST OF EUROPE
6.3. APAC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. REST OF APAC
6.4. REST OF THE WORLD
7. COMPANY PROFILES
7.1. ABBOTT LABORATORIES
7.2. AETNA INC
7.3. AGILENT TECHNOLOGIES
7.4. AKERS BIOSCIENCES, INC.
7.5. BIO-RAD LABORATORIES, INC
7.6. CIGNA
7.7. CLINICAL LAB PRODUCT
7.8. DIADEXUS
7.9. ERBA DIAGNOSTICS
7.10. HOLOGIC INC
7.11. LABORATORY CORPORATION OF AMERICA
7.12. NOVARTIS DIAGNOSTICS
7.13. QIAGEN
7.14. QUIDEL CORPORATION
7.15. ROCHE MOLECULAR SYSTEMS INC.
7.16. SIEMENS AG,
7.17. SYNAPSE DIAGNOSTICS
7.18. SYSMEX CORPORATION
7.19. THERMO FISHER SCIENTIFIC
7.20. TOSOH CORPORATION
LIST OF TABLES
TABLE 1 GLOBAL CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY DIAGNOSIS METHOD,2017-2023($ MILLION)
TABLE 2 GLOBAL CHLAMYDIA CULTURE MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 3 GLOBAL URINE CULTURE MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 4 GLOBAL ENZYME IMMUNOASSAYS MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 5 GLOBAL NUCLEIC ACID AMPLIFICATION TEST MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 6 GLOBAL CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY TREATMENT APPROACH,2017-2023($ MILLION)
TABLE 7 GLOBAL ORAL ANTIBIOTICS MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 8 GLOBAL CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY END-USER ,2017-2023($ MILLION)
TABLE 9 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 10 GLOBAL DIAGNOSTIC CENTRES RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 11 GLOBAL RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 12 NORTH AMERICA CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY DIAGNOSIS METHOD, 2017-2023($ MILLION)
TABLE 13 NORTH AMERICA CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY TREATMENT APPROACH, 2017-2023($ MILLION)
TABLE 14 NORTH AMERICA CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY END-USER, 2017-2023($ MILLION)
TABLE 15 EUROPE CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY DIAGNOSIS METHOD, 2017-2023($ MILLION)
TABLE 16 EUROPE CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY TREATMENT APPROACH, 2017-2023($ MILLION)
TABLE 17 EUROPE CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY END-USER, 2017-2023($ MILLION)
TABLE 18 ASIA PACIFIC CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY DIAGNOSIS METHOD, 2017-2023($ MILLION)
TABLE 19 ASIA PACIFIC CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY TREATMENT APPROACH, 2017-2023($ MILLION)
TABLE 20 ASIA PACIFIC CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY END-USER, 2017-2023($ MILLION)
TABLE 21 REST OF THE WORLD (ROW) CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 1 GLOBAL CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY DIAGNOSIS METHOD,2017-2023($ MILLION)
TABLE 2 GLOBAL CHLAMYDIA CULTURE MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 3 GLOBAL URINE CULTURE MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 4 GLOBAL ENZYME IMMUNOASSAYS MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 5 GLOBAL NUCLEIC ACID AMPLIFICATION TEST MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 6 GLOBAL CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY TREATMENT APPROACH,2017-2023($ MILLION)
TABLE 7 GLOBAL ORAL ANTIBIOTICS MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 8 GLOBAL CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY END-USER ,2017-2023($ MILLION)
TABLE 9 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 10 GLOBAL DIAGNOSTIC CENTRES RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 11 GLOBAL RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE 12 NORTH AMERICA CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY DIAGNOSIS METHOD, 2017-2023($ MILLION)
TABLE 13 NORTH AMERICA CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY TREATMENT APPROACH, 2017-2023($ MILLION)
TABLE 14 NORTH AMERICA CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY END-USER, 2017-2023($ MILLION)
TABLE 15 EUROPE CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY DIAGNOSIS METHOD, 2017-2023($ MILLION)
TABLE 16 EUROPE CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY TREATMENT APPROACH, 2017-2023($ MILLION)
TABLE 17 EUROPE CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY END-USER, 2017-2023($ MILLION)
TABLE 18 ASIA PACIFIC CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY DIAGNOSIS METHOD, 2017-2023($ MILLION)
TABLE 19 ASIA PACIFIC CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY TREATMENT APPROACH, 2017-2023($ MILLION)
TABLE 20 ASIA PACIFIC CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY END-USER, 2017-2023($ MILLION)
TABLE 21 REST OF THE WORLD (ROW) CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
LIST OF FIGURES
FIGURE 1 GLOBAL CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET SHARE, BY DIAGNOSIS METHODS, 2017 VS 2023($ MILLION)
FIGURE 2 GLOBAL CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET SHARE, BY TREATMENT APPROACH, 2017 VS 2023($ MILLION)
FIGURE 3 GLOBAL CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET SHARE, BY END-USER, 2017 VS 2023($ MILLION)
FIGURE 4 NORTH AMERICA CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 5 UNITED STATES CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 6 CANADA CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 7 EUROPE CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 8 UK CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 9 GERMANY CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 10 SPAIN CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 11 FRANCE CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 12 ITALY CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 13 REST OF EUROPE (ROE) CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 14 ASIA PACIFIC CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 15 INDIA CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 16 CHINA CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 17 JAPAN CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 18 ROAPAC CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 19 REST OF THE WORLD CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
COMPANIES MENTIONED
1. ABBOTT LABORATORIES
2. AETNA INC
3. AGILENT TECHNOLOGIES
4. AKERS BIOSCIENCES, INC.
5. BIO-RAD LABORATORIES, INC
6. CIGNA
7. CLINICAL LAB PRODUCT
8. DIADEXUS
9. ERBA DIAGNOSTICS
10. HOLOGIC INC
11. LABORATORY CORPORATION OF AMERICA
12. NOVARTIS DIAGNOSTICS
13. QIAGEN
14. QUIDEL CORPORATION
15. ROCHE MOLECULAR SYSTEMS INC.
16. SIEMENS AG,
17. SYNAPSE DIAGNOSTICS
18. SYSMEX CORPORATION
19. THERMO FISHER SCIENTIFIC
20. TOSOH CORPORATION
FIGURE 1 GLOBAL CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET SHARE, BY DIAGNOSIS METHODS, 2017 VS 2023($ MILLION)
FIGURE 2 GLOBAL CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET SHARE, BY TREATMENT APPROACH, 2017 VS 2023($ MILLION)
FIGURE 3 GLOBAL CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET SHARE, BY END-USER, 2017 VS 2023($ MILLION)
FIGURE 4 NORTH AMERICA CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 5 UNITED STATES CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 6 CANADA CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 7 EUROPE CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 8 UK CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 9 GERMANY CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 10 SPAIN CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 11 FRANCE CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 12 ITALY CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 13 REST OF EUROPE (ROE) CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 14 ASIA PACIFIC CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 15 INDIA CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 16 CHINA CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 17 JAPAN CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 18 ROAPAC CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE 19 REST OF THE WORLD CHLAMYDIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
COMPANIES MENTIONED
1. ABBOTT LABORATORIES
2. AETNA INC
3. AGILENT TECHNOLOGIES
4. AKERS BIOSCIENCES, INC.
5. BIO-RAD LABORATORIES, INC
6. CIGNA
7. CLINICAL LAB PRODUCT
8. DIADEXUS
9. ERBA DIAGNOSTICS
10. HOLOGIC INC
11. LABORATORY CORPORATION OF AMERICA
12. NOVARTIS DIAGNOSTICS
13. QIAGEN
14. QUIDEL CORPORATION
15. ROCHE MOLECULAR SYSTEMS INC.
16. SIEMENS AG,
17. SYNAPSE DIAGNOSTICS
18. SYSMEX CORPORATION
19. THERMO FISHER SCIENTIFIC
20. TOSOH CORPORATION
